IRCT20230705058684N1尚未招募2 期
Survey of Low-dose Heparin, Enoxaparin and Rivaroxaban as Prophylaxis against Venous Thromboembolism in Moderate to Severe Traumatic Brain Injury: A Randomized Clinical Trial Study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 70 years（—）
- 性别
- All
入选标准
- •Moderate to Severe Traumatic Brain Injury
- •Age between 16 and 70
- •Latency time between injury and entering the study of less than 6 h
- •Without history of coagulopathy
- •Caprini Score of 3 or greater
- •Closed head injury
- •Glasgow Coma Scale (GCS) between 3 and 13
- •AIS (Abbreviated Injury Score 3 or less than 3
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)Atrial FibrillationNCT00289042The Cleveland Clinic200
已完成
2 期
Heparin and deep vein thrombosisDeep vein throbmosis.Formation of thrombosis in the deep veinsIRCT201402113449N14Vice Chancellor for Research, Tehran University of Medical Sciences46
招募中
不适用
Difference between Heparin and Enoxaparin on inflammatory biomarkers in the treatment of heart attack (myocardial infarction).inflammatory cytokinCardiovascular - Coronary heart diseaseInflammatory and Immune System - Other inflammatory or immune system disordersSTEMIACTRN12611001139965Tehran university of medical science30
进行中（未招募）
1 期
Reduced-dosed rivaroxaban and standard-dosed rivaroxaban versus aspirin in the long-term prevention of blood clots from reccuring in the leg or lungong-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis and/or pulmonary embolismMedDRA version: 18.0Level: PTClassification code 10051055Term: Deep vein thrombosisSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 18.0Level: HLTClassification code 10037439Term: Pulmonary thrombotic and embolic conditionsSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 18.0Level: HLTClassification code 10034572Term: Peripheral embolism and thrombosisSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 18.0Level: PTClassification code 10037377Term: Pulmonary embolismSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2013-000619-26-DEBayer HealthCare AG2,850
进行中（未招募）
1 期
Reduced-dosed rivaroxaban and standard-dosed rivaroxaban versus aspirin in the long-term prevention of blood clots from reccuring in the leg or lungong-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis and/or pulmonary embolismMedDRA version: 19.0Level: PTClassification code 10051055Term: Deep vein thrombosisSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 19.0Level: HLTClassification code 10037439Term: Pulmonary thrombotic and embolic conditionsSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 19.0Level: HLTClassification code 10034572Term: Peripheral embolism and thrombosisSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 19.0Level: PTClassification code 10037377Term: Pulmonary embolismSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2013-000619-26-PLBayer AG3,300